{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:53Z","timestamp":1791425993071,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.coviro.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T08:00:42Z","timestamp":1460966442000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Animal models of yellow fever and their application in clinical research"],"prefix":"10.1016","volume":"18","author":[{"given":"Justin G","family":"Julander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.03.010_bib0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rmv.584","article-title":"The enigma of yellow fever in East Africa","volume":"18","author":"Ellis","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/S0036-46652013000100008","article-title":"Yellow fever epizootics in non-human primates, Sao Paulo state, Brazil, 2008\u20132009","volume":"55","author":"Moreno","year":"2013","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.coviro.2016.03.010_bib0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajp.21010","article-title":"Yellow fever outbreak affecting alouatta populations in southern Brazil (Rio Grande do Sul state), 2008\u20132009","volume":"74","author":"de Almeida","year":"2012","journal-title":"Am J Primatol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vaccine.2014.10.004","article-title":"Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk\/benefit assessment","volume":"33","author":"Monath","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.010_sbref0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.meegid.2013.03.008","article-title":"Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus","volume":"19","author":"Hanley","year":"2013","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0220","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2012.12.002","article-title":"Experimental therapies for yellow fever","volume":"97","author":"Julander","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.03.010_bib0225","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.142287799","article-title":"Positional cloning of the murine flavivirus resistance gene","volume":"99","author":"Perelygin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.03.010_bib0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","article-title":"The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon","volume":"16","author":"Laurent-Rolle","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2016.03.010_sbref0235","doi-asserted-by":"crossref","first-page":"e0003693","DOI":"10.1371\/journal.pntd.0003693","article-title":"A DNA vaccine against yellow fever virus: development and evaluation","volume":"9","author":"Maciel","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.03.010_bib0240","doi-asserted-by":"crossref","first-page":"e24505","DOI":"10.1371\/journal.pone.0024505","article-title":"Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever","volume":"6","author":"Schafer","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2016.03.010_bib0245","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0250","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biologicals.2013.04.005","article-title":"Yellow fever vaccine: comparison of the neurovirulence of new 17D-204 stamaril seed lots and RK 168-73 strain","volume":"41","author":"Moulin","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.coviro.2016.03.010_bib0255","doi-asserted-by":"crossref","first-page":"e1000614","DOI":"10.1371\/journal.ppat.1000614","article-title":"A mouse model for studying viscerotropic disease caused by yellow fever virus infection","volume":"5","author":"Meier","year":"2009","journal-title":"PLoS Pathog"},{"issue":"Pt 6","key":"10.1016\/j.coviro.2016.03.010_sbref0260","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1099\/vir.0.000075","article-title":"Spectrum of disease outcomes in mice infected with yfv-17d","volume":"96","author":"Erickson","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2014.07.050","article-title":"Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice","volume":"468\u2013470","author":"Tretyakova","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.03.010_bib0270","doi-asserted-by":"crossref","first-page":"12392","DOI":"10.1128\/JVI.02149-13","article-title":"Dynamic viral dissemination in mice infected with yellow fever virus strain 17D","volume":"87","author":"Erickson","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0275","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.vaccine.2012.03.003","article-title":"A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain","volume":"30","author":"Thibodeaux","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.010_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2012.02.001","article-title":"A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129\/17D-204 peripheral challenge mouse model","volume":"94","author":"Thibodeaux","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.03.010_bib0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2013.12.011","article-title":"Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model","volume":"103","author":"Julander","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.03.010_bib0290","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2014.09.004","article-title":"MEK\/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target","volume":"111","author":"Albarnaz","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.03.010_bib0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.03.010_sbref0300","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1128\/AAC.03368-14","article-title":"BCX4430, a novel nucleoside analog, effectively treats yellow fever in a hamster model","volume":"58","author":"Julander","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.03.010_bib0305","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.01074-08","article-title":"Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106","volume":"53","author":"Julander","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.03.010_bib0310","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.03.010_sbref0315","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.03.010_sbref0320","doi-asserted-by":"crossref","first-page":"e109755","DOI":"10.1371\/journal.pone.0109755","article-title":"Efficient gene targeting in golden Syrian hamsters by the CRISPR\/Cas9 system","volume":"9","author":"Fan","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.03.010_bib0325","doi-asserted-by":"crossref","first-page":"e1005084","DOI":"10.1371\/journal.ppat.1005084","article-title":"Stat2 knockout Syrian hamsters support enhanced replication and pathogenicity of human adenovirus, revealing an important role of type I interferon response in viral control","volume":"11","author":"Toth","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.03.010_bib0330","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever","volume":"60","author":"Monath","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.coviro.2016.03.010_bib0335","first-page":"169","article-title":"Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes","volume":"1","author":"Li","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0340","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.12.010","article-title":"Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy","volume":"115","author":"Beasley","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.03.010_bib0345","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.1001191","article-title":"Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host","volume":"186","author":"Mandl","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.03.010_bib0350","doi-asserted-by":"crossref","first-page":"e3295","DOI":"10.1371\/journal.pntd.0003295","article-title":"Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model","volume":"8","author":"Engelmann","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.03.010_bib0355","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1016\/j.vaccine.2011.06.034","article-title":"Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model","volume":"29","author":"Julander","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.010_bib0360","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"Monath","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.010_bib0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biologicals.2011.04.001","article-title":"Neurovirulence tests of three 17D yellow fever vaccine strains","volume":"39","author":"Minor","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.coviro.2016.03.010_bib0370","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1016\/j.vaccine.2010.09.090","article-title":"CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-gamma at 5\u20137 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses","volume":"28","author":"Neves","year":"2010","journal-title":"Vaccine"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T03:22:59Z","timestamp":1536808979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716300426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":37,"alternative-id":["S1879625716300426"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.03.010","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of yellow fever and their application in clinical research","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}